| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/02/2008 | CN101152554A Traditional Chinese medicine for treating urticaria, that is for reliving heat and eliminating anthema |
| 04/02/2008 | CN101152516A Compound traditional Chinese medicine preparation about silk moth and method for preparing the same |
| 04/02/2008 | CN101152512A Traditional Chinese medicine for treating allergic dermatitis |
| 04/02/2008 | CN101152443A Traditional Chinese medicine for treating urticaria, that is for benefiting Qi and eliminating damp |
| 04/02/2008 | CN101152318A Traditional Chinese medicine with cooperativeness therapy |
| 04/02/2008 | CN101152276A Traditional Chinese medicine for treating urticaria, that is for expelling wind and preventing anthema |
| 04/02/2008 | CN101152253A Traditional Chinese medicine for treating various rhinitis |
| 04/02/2008 | CN101152237A Method of preparing kudzu root flavone chewing chips |
| 04/02/2008 | CN101152197A Compound glycyrrhizin dropping pills and method for preparing the same |
| 04/02/2008 | CN101152181A Liquid composition containing loratadine and ambroxol hydrochloride |
| 04/02/2008 | CN101152179A Application of isoniazide as histone deacetylase inhibitors |
| 04/02/2008 | CN101152170A Capsule containing pseudoephedrine and method for preparing the same |
| 04/02/2008 | CN100378214C Probiotic bacterium: lactobacillus fermentum |
| 04/02/2008 | CN100378125C Bionic affinity purifying process of interleukin I natural agonist |
| 04/02/2008 | CN100378123C Chimeric chains that code for proteins that induce effects directed against viruses |
| 04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 04/02/2008 | CN100378116C High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/02/2008 | CN100378047C Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 04/02/2008 | CN100377679C 椅子 Chair |
| 04/01/2008 | US7351875 Using recombinant rodent which expresses Fc gamma RIIa receptor as tool in identifying modulators for treatment and prevention of arthritic and autoimmune disorders |
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 04/01/2008 | US7351554 Administering vaccine, native E7 protein, inactive fragment of the immunosuppressive and/or angiogenic native E7 protein;a DNA molecule encoding immunosuppressive and/or angiogenic native E7 protein inactivated by mutation; adjuvant of mucosal immunity |
| 04/01/2008 | US7351524 Diagnostics and therapeutics for macular degeneration-related disorders |
| 04/01/2008 | CA2471952C Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 04/01/2008 | CA2372614C Process and product for enhancing immune response in companion animal using a combination of antioxidants |
| 04/01/2008 | CA2341240C Autoantibody inhibitors |
| 03/27/2008 | WO2008036809A2 Methods and materials for reducing risk of cold and/or flu |
| 03/27/2008 | WO2008036642A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008036312A1 Fungicidal methods using immune response modifier compounds |
| 03/27/2008 | WO2008036277A1 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 03/27/2008 | WO2008035757A1 Jelly-like food containing ubiquinol |
| 03/27/2008 | WO2008035239A1 Phenyl derivatives and their use as immunomodulators |
| 03/27/2008 | WO2008034815A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | WO2008034600A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | WO2008012563A3 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
| 03/27/2008 | WO2008006895A3 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 03/27/2008 | WO2008005621A3 Compositions and methods for modulating immune responses |
| 03/27/2008 | WO2008001110A3 Manganese, zinc and selenium compositions, preparations and uses |
| 03/27/2008 | WO2007132179A3 Therapeutics comprising pyridinium derivatives |
| 03/27/2008 | WO2007092939A3 Antigenic gm-csf peptides and antibodies to gm-csf |
| 03/27/2008 | WO2007020411A8 Amide derivatives |
| 03/27/2008 | US20080076921 Inhibitors of bruton's tyrosine kinase |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076755 4-(Adamantane-1-carbonylamino)-3-oxo-2-aza-bicyclo[2.2.2]octane; 5-(Adamantane-1-carbonylamino)-10-oxo-9-aza-bicyclo[3.3.2]decane for treating autoimmune diseases, vascular disorders, viral infection or replication, asthma, osteoporosis, tumor growth, rheumatoid arthritis, organ transplant rejection |
| 03/27/2008 | US20080076744 Method for treating inflammatory conditions with progesterone or progesterone analogs |
| 03/27/2008 | US20080076714 oral or mucosal administration for treating immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease and other inflammatory diseases; drug delivery method |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076146 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 03/27/2008 | US20080075769 Psychostimulant containing pharmaceutical composition |
| 03/27/2008 | US20080075765 Methods and materials for reducing risk of cold and/or flu |
| 03/27/2008 | US20080075742 synergistic biomedical activity as immunostimulants; biodrugs for prevention and/or treatment of cancer, treatment of allergic conditions, malignancies, chronic infections, autoimmune phenomena and age-related imbalances; adverse side effects of irradiation |
| 03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
| 03/27/2008 | US20080075730 Methods and compositions for treating biofilms |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
| 03/27/2008 | US20080075712 replacement for ligand of a heteromolecule-comprising a dimer, cytokine or interferon receptors; antibodies recognizing both an enzyme and a substrate, such as proteolytic enzymes and blood coagulation/fibrinolysis associated factors; prevention of bleeding and/or blood disorders |
| 03/27/2008 | US20080075705 induction of endogenous heat shock proteins in tumor cells, bysimple heat treatment as a method for augmenting antitumor vaccine potency |
| 03/27/2008 | US20080075697 administering therapeutic effective dose of human interferon-beta mutein (hIFN- beta ser17), two times per week or three times per week by intramuscular injection |
| 03/27/2008 | CA2663791A1 Pyrazolo (1, 5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 03/27/2008 | CA2663269A1 Combination of nmda-receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | CA2662673A1 Phenyl derivatives and their use as immunomodulators |
| 03/27/2008 | CA2662359A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | CA2660795A1 Optimized antibodies that target hm1.24 |
| 03/27/2008 | CA2646909A1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 03/27/2008 | CA2645185A1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1902733A1 Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity |
| 03/26/2008 | EP1902720A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis |
| 03/26/2008 | EP1902710A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1901773A2 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection |
| 03/26/2008 | EP1901766A2 Use of fril proteins for reducing the production of pro-inflammatory cytokines |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1901724A1 Percutaneously absorptive ophthalmic preparation comprising epinastine |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP0879060B1 Vaccines against varicella zoster virus gene 63 product |
| 03/26/2008 | EP0764029B2 Proteinaceous adjuvants |
| 03/26/2008 | CN101151278A CD20 antibody variants and uses thereof |
| 03/26/2008 | CN101151050A Agent for control of degranulation reaction and cytokine production |
| 03/26/2008 | CN101151041A Composition for immune activation |